biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by narmacon Dec 17, 2022 6:39am

271 Views

Post# 35177390

Questions for Graeme !

So send me your questions in a PM by Sunday afternoon, (private message) and Ill get them off to Graeme.

If we can narrow them down to 10 with the most important ones in the top we might get a few answers.
Maybe,,a big maybe!

And sorry Graeme,,but SH dont likke your last name. :o)

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments